A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
NCT00308191 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 128
Last updated 2008-03-07
Summary
The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.
Conditions
Interventions
- DRUG
-
Formoterol Fumarate
- DRUG
-
Tiotropium Bromide
Sponsors & Collaborators
-
Dey
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2006-05-31
- Completion
- 2006-12-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD
NCT00530842 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)
NCT00424528 ·Status: COMPLETED ·Phase: PHASE4
-
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
NCT00680056 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.
NCT00359788 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD
NCT00662792 ·Status: COMPLETED ·Phase: PHASE3
-
SERETIDE Plus Tiotropium Versus Individual Components
NCT00325169 ·Status: COMPLETED ·Phase: PHASE2
-
The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium
NCT01899742 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease
NCT00846586 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00274092 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01372410 ·Status: COMPLETED ·Phase: PHASE2
-
AMPLIFY - D6571C00001 Duaklir USA Phase III Study
NCT02796677 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease
NCT00877383 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD
NCT02603393 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy
NCT04184297 ·Status: COMPLETED
-
Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD
NCT02683109 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)
NCT00900731 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
NCT00515502 ·Status: COMPLETED ·Phase: PHASE2
-
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
NCT01316913 ·Status: COMPLETED ·Phase: PHASE3
-
26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00463567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02242253 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
NCT00239434 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00871182 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
NCT00361959 ·Status: COMPLETED ·Phase: PHASE4
-
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
NCT00563381 ·Status: COMPLETED ·Phase: PHASE4
-
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease
NCT00134979 ·Status: COMPLETED ·Phase: PHASE4